Phio Pharmaceuticals Corp... (PHIO)

AI Score

Unlock

1.09

-0.08 (-6.84%)

At close: Apr 04, 2025, 1:17 PM

Phio Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Cash & Equivalents	5.38M	8.49M	11.78M	24.06M	14.24M	6.93M	14.88M	3.58M	12.91M	5.12M	8.5M	11.39M	5.13M	503K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.5M	n/a	3M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	154.5K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	3K	24K	27K	18K	18K	n/a	18K	22.5K	18K	18K	18K	2K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	597K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	354K	832K	665K	50K	50K	50K	50K	50K	50K	50K	50K	50K	53K	53K
Total Current Assets	5.74M	9.32M	12.45M	24.73M	15.16M	7.3M	15.15M	3.83M	13.11M	10.98M	8.99M	14.74M	5.39M	1.34M
Property-Plant & Equipment	2K	39K	344K	416K	557K	721K	172K	248K	114K	163K	183K	177K	198K	355K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2K	42K	368K	443K	575K	739K	172K	266K	291K	181K	201K	195K	200K	355K
Total Assets	5.74M	9.36M	12.81M	25.17M	15.74M	8.04M	15.32M	4.1M	13.4M	11.16M	9.19M	14.94M	5.59M	1.69M
Account Payables	253K	657K	779K	283K	728K	809K	550K	511K	917K	1.16M	285K	163K	416K	387K
Deferred Revenue	n/a	n/a	n/a	n/a	1.25M	937K	n/a	n/a	n/a	n/a	47K	118K	491K	816K
Short-Term Debt	n/a	n/a	135K	125K	116K	107K	n/a	n/a	n/a	n/a	n/a	n/a	5K	n/a
Other Current Liabilities	762K	720K	482K	1.96M	606K	333K	n/a	n/a	n/a	n/a	474K	1.17M	359K	309K
Total Current Liabilities	1.01M	1.63M	1.8M	3.07M	2.2M	1.88M	1.74M	2.27M	2.54M	2.27M	1.33M	2.08M	1.68M	1.78M
Long-Term Debt	n/a	n/a	n/a	n/a	231K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	500K
Other Long-Term Liabilities	n/a	n/a	2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.11M	n/a	9.73M	n/a
Total Long-Term Liabilities	n/a	n/a	172K	170K	526K	411K	n/a	n/a	n/a	n/a	5.11M	7.92M	9.75M	505K
Total Liabilities	1.01M	1.63M	1.98M	3.24M	2.72M	2.29M	1.74M	2.27M	2.54M	2.27M	6.44M	10M	11.43M	2.28M
Total Debt	n/a	35K	305K	295K	642K	518K	n/a	n/a	n/a	n/a	n/a	n/a	5K	534K
Common Stock	n/a	n/a	n/a	1K	1K	1K	2K	n/a	1K	7K	2K	1K	16K	10K
Retained Earnings	-146.36M	-139.21M	-128.38M	-116.9M	-103.61M	-94.82M	-85.91M	-78.55M	-66.1M	-57.1M	-46.88M	-38.08M	-17.16M	-4.28M
Comprehensive Income	n/a	-0.00	n/a	0.00	n/a	n/a	-981K	-900K	-831K	-778K	-702K	-632K	-585K	-646K
Shareholders Equity	4.72M	7.73M	10.84M	21.93M	13.02M	5.75M	13.58M	1.83M	10.86M	8.89M	2.75M	4.94M	-5.84M	-587K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	154.5K	5.5M	n/a	3M	n/a	n/a